Should we rely on trials with disease- rather than patient-oriented endpoints?

Harm Jan de Grooth*, Jean Jacques Parienti, Heleen M. Oudemans-van Straaten

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)464-466
Number of pages3
JournalIntensive Care Medicine
Volume44
DOIs
Publication statusPublished - 2018

Cite this